BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21191065)

  • 21. Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma.
    Ma J; Wang S; Ma B; Mao C; Tong J; Yang M; Wu C; Jiao Z; Lu L; Xu H
    Cancer Lett; 2011 Feb; 301(2):142-50. PubMed ID: 21186078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of interleukin-10 signaling in lung dendritic cells by toll-like receptor 4 ligands.
    Jose P; Avdiushko MG; Akira S; Kaplan AM; Cohen DA
    Exp Lung Res; 2009 Feb; 35(1):1-28. PubMed ID: 19191102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of spontaneous metastatic lung cancer with interleukin-12 gene-modified dendritic cells vaccine].
    Chen JQ; Xiu QY; Shen C; Yan ZM
    Ai Zheng; 2002 Dec; 21(12):1328-31. PubMed ID: 12520741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
    Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
    J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-1-matured human monocyte-derived dendritic cells have enhanced migration through extracellular matrix.
    Fulcher JA; Hashimi ST; Levroney EL; Pang M; Gurney KB; Baum LG; Lee B
    J Immunol; 2006 Jul; 177(1):216-26. PubMed ID: 16785517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation].
    Xia JB; Wang CZ; Ma JX; An XJ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):514-8. PubMed ID: 19567068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment and differentiation of conventional dendritic cell precursors in tumors.
    Diao J; Zhao J; Winter E; Cattral MS
    J Immunol; 2010 Feb; 184(3):1261-7. PubMed ID: 20026742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
    Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS
    Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
    Okada N; Iiyama S; Okada Y; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
    Cancer Gene Ther; 2005 Jan; 12(1):72-83. PubMed ID: 15389286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function.
    Katsenelson NS; Shurin GV; Bykovskaia SN; Shogan J; Shurin MR
    Mod Pathol; 2001 Jan; 14(1):40-5. PubMed ID: 11211308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.
    Hsu YL; Wu CY; Hung JY; Lin YS; Huang MS; Kuo PL
    Carcinogenesis; 2013 Jun; 34(6):1370-81. PubMed ID: 23389289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
    Hsu YL; Hung JY; Chiang SY; Jian SF; Wu CY; Lin YS; Tsai YM; Chou SH; Tsai MJ; Kuo PL
    Oncotarget; 2016 May; 7(19):27584-98. PubMed ID: 27050278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer.
    Yao Y; Li H; Chen J; Xu W; Yang G; Bao Z; Xia D; Lu G; Hu S; Zhou J
    Oncotarget; 2016 May; 7(20):29620-34. PubMed ID: 27102437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments.
    Soldati R; Berger E; Zenclussen AC; Jorch G; Lode HN; Salatino M; Rabinovich GA; Fest S
    Int J Cancer; 2012 Sep; 131(5):1131-41. PubMed ID: 22020795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myosin IIa activation is crucial in breast cancer derived galectin-1 mediated tolerogenic dendritic cell differentiation.
    Cheng DE; Hung JY; Huang MS; Hsu YL; Lu CY; Tsai EM; Hou MF; Kuo PL
    Biochim Biophys Acta; 2014 Jun; 1840(6):1965-76. PubMed ID: 24468067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.